We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
Cap. Flow
-$915M
Cap. Flow %
-1.97%
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169

Top Buys

Rank Stock Value
1
BRO icon
Brown & Brown
BRO
+$161M
2
CHD icon
Church & Dwight Co
CHD
+$150M
3
AMD icon
Advanced Micro Devices
AMD
+$78.9M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$56.9M
5
AZN icon
AstraZeneca
AZN
+$53.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$170M
2
T icon
AT&T
T
+$142M
3
MSFT icon
Microsoft
MSFT
+$136M
4
XLNX
Xilinx Inc
XLNX
+$110M
5
AMZN icon
Amazon
AMZN
+$86.9M

Sector Composition

Rank Sector Weight
1 Technology 31.53%
2 Consumer Discretionary 13.24%
3 Communication Services 9.89%
4 Healthcare 9.39%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
2151
DELISTED
DURECT Corp
DRRX
$29K ﹤0.01%
4,242
-700
-14% -$4.87K
NCMI icon
2152
National CineMedia
NCMI
$354M
$29K ﹤0.01%
1,127
-186
-14% -$5.18K
PBYI icon
2153
Puma Biotechnology
PBYI
$406M
$29K ﹤0.01%
10,284
-2,523
-20% -$6.53K
SYRE icon
2154
Spyre Therapeutics
SYRE
$8.87B
$29K ﹤0.01%
507
-124
-20% -$10.4K
LTRPA
2155
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$29K ﹤0.01%
13,659
-2,258
-14% -$4.78K
INFI
2156
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$29K ﹤0.01%
25,623
-6,038
-19% -$7.21K
MILE
2157
DELISTED
Metromile, Inc. Common Stock
MILE
$29K ﹤0.01%
21,381
+435
+2% +$630
ATOS icon
2158
Atossa Therapeutics
ATOS
$22.9M
$28K ﹤0.01%
1,462
-242
-14% -$4.92K
WVE icon
2159
Wave Life Sciences
WVE
$1.12B
$28K ﹤0.01%
14,386
-3,568
-20% -$8.74K
ASXC
2160
DELISTED
Asensus Surgical, Inc.
ASXC
$28K ﹤0.01%
43,870
-7,248
-14% -$5.58K
RMO
2161
DELISTED
Romeo Power, Inc.
RMO
$28K ﹤0.01%
18,342
-9,913
-35% -$20.9K
SLDB icon
2162
Solid Biosciences
SLDB
$771M
$27K ﹤0.01%
1,506
-398
-21% -$7.02K
QMCO icon
2163
Quantum Corp
QMCO
$437M
$26K ﹤0.01%
556
-83
-13% -$6.08K
NMTR
2164
DELISTED
9 Meters Biopharma
NMTR
$26K ﹤0.01%
2,123
-350
-14% -$4.78K
SFT
2165
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$26K ﹤0.01%
1,127
-229
-17% -$5.08K
SIEN
2166
DELISTED
Sientra, Inc.
SIEN
$24K ﹤0.01%
1,089
-179
-14% -$4.9K
DS
2167
DELISTED
Drive Shack Inc.
DS
$24K ﹤0.01%
15,489
-2,561
-14% -$3.48K
ATHX
2168
DELISTED
Athersys, Inc. Common Stock
ATHX
$24K ﹤0.01%
1,597
-193
-11% -$4.04K
AQB icon
2169
AquaBounty Technologies
AQB
$4.68M
$23K ﹤0.01%
614
+41
+7% +$1.43K
MBIO icon
2170
Mustang Bio
MBIO
$4.26M
$23K ﹤0.01%
31
-8
-21% -$6.57K
ERNA icon
2171
Eterna Therapeutics
ERNA
$4.58M
$22K ﹤0.01%
1
-1
-50% -$19K
ATNX
2172
DELISTED
Athenex, Inc. Common Stock
ATNX
$22K ﹤0.01%
1,379
-335
-20% -$6.55K
SYRS
2173
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$21K ﹤0.01%
1,721
-409
-19% -$7.32K
NGNE icon
2174
Neurogene
NGNE
$696M
$20K ﹤0.01%
550
-133
-19% -$7.76K
MBII
2175
DELISTED
Marrone Bio Innovations, Inc.
MBII
$20K ﹤0.01%
18,983
-3,136
-14% -$2.37K
85 86
87
88 89

Similar funds

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

ProShare Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
  • ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
  • ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
  • ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
  • ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
  • ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
  • ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.